Alex Shlyankevich

Alex Shlyankevich is an experienced investment professional currently serving as Investment Director at Mansfield Bio-Incubator and Venture Partner at Asymmetry Ventures. Additionally, Alex holds advisory and board member roles at GiveVision, Constant Therapeutics, Felicitex Therapeutics, and NuPulseCV, contributing to advancements in accessibility and healthcare innovations. Alex also presides over Orot Yerushalaim and partners with MH Biomedical Investments to manage a diverse healthcare investment portfolio. Formerly a Senior Healthcare Analyst-Consultant at Forrester, Alex consulted on co-innovation strategies and patient outcomes in the pharmaceutical sector. Academic credentials include a Ph.D. in Pharmaceutical Analysis and a Master’s Degree in Pharmacy from First Moscow State Medical University.